DFORF yields 2.33% · MRK yields 2.76%● Live data
📍 MRK pulled ahead of the other in Year 1
Combined, DFORF + MRK cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of DFORF + MRK for your $10,000?
Celebrus Technologies plc, together with its subsidiaries, provides information technology products and services. It offers Celebrus, a disruptive data technology platform for improving relationships between brands and consumers. The company also provides Celebrus CDI for Salesforce that captures real-time data; Celebrus Digital Analytics, a web analytics platform; and Celebrus Cloud, that automates the intake, integration, transformation, and delivery of customer data. In addition, it offers fraud prevention through its platform. The company serves finance and banking, retail, travel, healthcare, and telecom sectors in the United Kingdom, rest of Europe, the United States, and internationally. The company was formerly known as D4t4 Solutions Plc and changed its name to Celebrus Technologies plc in November 2023. Celebrus Technologies plc was incorporated in 1985 and is headquartered in Sunbury-on-Thames, the United Kingdom.
Full DFORF Calculator →Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.
Full MRK Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.